Olapragen-150
| Packed: |
150 mg / 30 Tablets |
|---|---|
| Manufacturer: |
Hetero Labs Limited |
| Active ingredient: |
Olaparib Tablets 150 mg |
Supportive monotherapy for platinum-sensitive relapse of serous epithelial ovarian, fallopian tube, or primary peritoneal cancer of high grade malignancy with a germline (hereditary) BRCA gene mutation and/or a somatic BRCA gene mutation (occurring in tumor cells) in adult patients who have responded (complete or partial response) to a platinum-containing chemotherapy regimen.
